RVMD
-6.5%🔴 Potential overreactionRevolution Medicines, Inc. Common Stock · Healthcare
What happened
Why it moved
- Needham Reiterates Buy on Revolution Medicines, Maintains $275 Price Target — finnhub-news
- RBC Capital Maintains Outperform on Revolution Medicines, Raises Price Target to $260 — finnhub-news
Weak signal: analyst action, 5.4pp below its sector.
Verdict — was the move justified?
🔴 Potential overreaction
A 2.7σ move well beyond the sector with no identified fundamental or news driver — the reaction appears larger than currently visible evidence justifies. Likely flow/positioning-driven.
How unusual is this move
Today’s move is among the largest 6% of RVMD’s daily moves over the last 5 years — while the sector moved -1.1% and the market -0.5%.
What happened after similar moves
87 similar down moves in RVMD’s 5-year history:
Median of same-direction moves within ±35% magnitude band. Past patterns don’t predict outcomes — context, not signal.
Fundamental context
Insider activity (90d): net selling $2.49M
Full fundamental analysis on PreMarketPrice
Pillar scores, financial statements, valuation history, news & more for RVMD